Clinical Trial News and Research

RSS

Precision NanoSystems launches NanoAssemblr Scale-Up system to support production of novel medicines

Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines.

From Precision NanoSystems Inc. 9 Mar 2017

Mayo Clinic researchers find new experimental drug that shrinks tumors in multiple myeloma patients

Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.

8 Mar 2017

Early death from pediatric cancer subtypes more likely to happen than previously reported

Treatments for childhood cancers have improved to the point that 5-year survival rates are over 80 percent. However, one group has failed to benefit from these improvements, namely children who die so soon after diagnosis that they are not able to receive treatment, or who receive treatment so late in the course of their disease that it is destined to fail.

8 Mar 2017

Study reveals promising new strategy to attack deadly pediatric brain tumor

Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG), may develop.

7 Mar 2017

Experts join forces to study affordable malaria drug for treating colorectal cancer

Experts from St George's University of London, and St George's Hospital have joined forces to investigate whether a common and cheap malaria drug can be used also against cancer.

7 Mar 2017

Clinical study seeks to examine new combination therapy for treating AML patients

A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.

7 Mar 2017

Nanomaterial-based bone regeneration technology could help people suffering from severe injuries

Advanced materials are revolutionizing our daily lives — from clothing to clinics to … cattle? A nanomaterial-based bone regeneration technology developed at the University of Arkansas at Little Rock helped save a valuable animal's life. In the future, this technology could help people suffering from a variety of severe injuries and ailments.

7 Mar 2017

Study finds link between extended use MAO-B inhibitors and slow clinical decline in PD patients

There has long been interest in whether monoamine oxidase type B (MAO-B) inhibitors slow progression of Parkinson's disease (PD) and improve long-term outcomes.

6 Mar 2017

Study finds link between vitamin D levels and severity of malabsorption issues

Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason, to take a vitamin D supplement to reduce Crohn’s flare-ups.

From BetterYou Ltd 3 Mar 2017

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Mount Sinai researchers have discovered that a rheumatoid arthritis drug can block a metabolic pathway that occurs in tumors with a common cancer-causing gene mutation, offering a new possible therapy for aggressive cancers with few therapeutic options, according to a study to be published in Cancer Discovery.

3 Mar 2017

Innovative gene therapy allows complete remission of clinical signs of sickle cell disease

A team led by Pr. Marina Cavazzana conducted at Necker Children's Hospital, AP-HP and the Imagine Institute in October 2014 gene therapy in the context of a phase I clinical trial / II in a patient 13 years with severe sickle cell disease.

2 Mar 2017

First-ever clinical study shows that older adults benefit from hearing aid use

The first-ever placebo-controlled, double-blind, randomized clinical trial of hearing aid outcomes published today in the American Journal of Audiology shows that older adults benefit from hearing aid use.

2 Mar 2017

Cholesterol-processing enzyme could be therapeutic target to stave off neurologic diseases

An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.

2 Mar 2017

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Chemotherapy treatment targets and kills cancer cells in the body. However, even after treatment, some cancer cells may remain in the patient's system undetected.

2 Mar 2017

Researchers probe potential link between gut microbiota and poor artery health

Scientific evidence that the assortment of gut microbes in humans influences different and critical aspects of health is piling up: Researchers think our microbes may influence obesity, anxiety, depression, autism, cancer and gastrointestinal diseases.

1 Mar 2017

$Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer$

Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer

Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer.

1 Mar 2017

First Philips Avent Global Scientific Symposium enables experts to discuss impact, opportunities for global breastfeeding practices

Today Royal Philips announced that the first Philips Avent Global Scientific Symposium took place in London on February 16-17th 2017, bringing together 70 healthcare professionals in the field of breastfeeding and infant feeding practice to share their latest knowledge and experiences.

From Philips Healthcare 1 Mar 2017

New London Major Early-Phase Contract Research Center Opened on Rare Disease Day

Richmond Pharmacology, one of the UK’s leading early-phase contract research organisations, have today opened their new research facility in London Bridge – at the site formerly known as the Guy’s Drug Research Unit. The move is a significant boost to the UK’s efforts to continue to grow as a global hub for Life Sciences, an area of strategic importance outlined in the Government’s recent industrial strategy.

1 Mar 2017

Novel non-pharmacological approach shows promise to manage chronic pain

Chronic pain afflicts over 100 million people across the United States. It diminishes their productivity and their quality of life and costs hundreds of billions of dollars each year to medically manage. It shatters people's emotional wellbeing, tears apart families and claims lives through suicides and accidental drug overdoses.

1 Mar 2017

UC scientists discover new strategy to personalize blood, brain cancer therapy

Researchers at the University of Cincinnati College of Medicine have discovered a new potential strategy to personalize therapy for brain and blood cancers.

1 Mar 2017

Clinical Trial News and Research

Precision NanoSystems launches NanoAssemblr Scale-Up system to support production of novel medicines

Mayo Clinic researchers find new experimental drug that shrinks tumors in multiple myeloma patients

Early death from pediatric cancer subtypes more likely to happen than previously reported

Study reveals promising new strategy to attack deadly pediatric brain tumor

Experts join forces to study affordable malaria drug for treating colorectal cancer

Clinical study seeks to examine new combination therapy for treating AML patients

Nanomaterial-based bone regeneration technology could help people suffering from severe injuries

Study finds link between extended use MAO-B inhibitors and slow clinical decline in PD patients

Study finds link between vitamin D levels and severity of malabsorption issues

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Innovative gene therapy allows complete remission of clinical signs of sickle cell disease

First-ever clinical study shows that older adults benefit from hearing aid use

Cholesterol-processing enzyme could be therapeutic target to stave off neurologic diseases

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Researchers probe potential link between gut microbiota and poor artery health

Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer

First Philips Avent Global Scientific Symposium enables experts to discuss impact, opportunities for global breastfeeding practices

New London Major Early-Phase Contract Research Center Opened on Rare Disease Day

Novel non-pharmacological approach shows promise to manage chronic pain

UC scientists discover new strategy to personalize blood, brain cancer therapy

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer